Influenza is an acute respiratory illness caused by influenza A or B virus: abrupt fever, myalgia, headache and dry cough, with a risk of viral or bacterial pneumonia in the old, the very young, pregnant women and people with chronic disease. Other respiratory viruses (rhinovirus, parainfluenza, RSV, adenovirus, metapneumovirus, SARS-CoV-2) give overlapping syndromes. Infectious mononucleosis is the clinical face of primary Epstein–Barr virus (EBV) infection in adolescents and young adults.
The key to diagnosis: influenza by nasopharyngeal swab RT-PCR (molecular test) in season, with treatment not waiting for the result in high-risk patients; mononucleosis by the triad of fever, exudative pharyngitis and posterior cervical lymphadenopathy, atypical lymphocytes and a heterophile test or EBV serology.
The key to treatment: oseltamivir 75 mg twice daily for 5 days for influenza in hospitalised, severe or high-risk patients at any time from onset; supportive care only for mononucleosis, with no contact sport for weeks because of splenic rupture. Influenza epidemiology: topic 6; vaccines: topic 26.